Cover Image
市場調查報告書

女性的健康的全球市場:2016年∼2020年

Global Womens Health Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 307873
出版日期 內容資訊 英文 65 Pages
訂單完成後即時交付
價格
Back to Top
女性的健康的全球市場:2016年∼2020年 Global Womens Health Market 2016-2020
出版日期: 2016年04月12日 內容資訊: 英文 65 Pages
簡介

全球女性健康市場,預計2016年∼2020年以3%以上的年複合成長率成長。許多國家改善醫療設施,隨之市場也預計前景樂觀。

本報告提供全球女性的健康市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

第1章 摘要整理

第2章 調查範圍

  • 市場概要
  • 主要供應商產品

第3章 市場調查手法

  • 調查手法
  • 經濟指標

第4章 簡介

  • 主要市場焦點

第5章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 市場區隔:各適用

  • 市場概要
  • 停經後骨質疏鬆症
  • 避孕藥
  • 不孕症
  • 更年期障礙
  • 子宮內膜異位症
  • 多囊性卵巢症候群

第7章 地理區分

  • 市場概要
  • 南北美洲
  • 歐洲
  • 亞太地區
  • 中東、非洲

第8章 推動市場要素

第9章 推動因素的影響

第10章 市場課題

第11章 推動因素與課題的影響

第12章 市場趨勢

第13章 業者情勢

  • 競爭模式

第14章 主要供應商分析

  • Allergan
  • Bayer HealthCare
  • Merck
  • Pfizer
  • Teva Pharmaceuticals
  • 其他卓越供應商

第15章 附錄

  • 簡稱清單

第16章 關於Technavio

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR9224

About Global Directed Energy Weapons Market 2016-2020

A directed-energy weapon (DEW) is the future weapon system that emits highly focused energy for target destruction. The potential applications of this advanced technology include anti-personnel weapon systems, missile defense system, and the disabling of lightly armored vehicles. The use of DEW systems is much more cost-effective than the massive cost associated with a single missile launch. With fast-track innovations in the military technology, such weapons are tools for future warfare.

Technavio's analysts forecast the global DEW market to grow at a CAGR of 29.03% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global directed energy weapons (DEW) market for 2016-2020.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Directed Energy Weapons Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • BAE Systems
  • Boeing
  • Lockheed Martin Corp.
  • Northrop Grumman Corp.
  • Raytheon Co

Other Prominent Vendors

  • Finmeccanica
  • Israel Aerospace Industries
  • Saab
  • Thales Group

Market driver

  • Growing demand for non-lethal weapons
  • For a full, detailed list, view our report

Market challenge

  • Defense budget cuts
  • For a full, detailed list, view our report

Market trend

  • Increasing investments in R&D
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by application

  • Market overview
  • Global postmenopausal osteoporosis market
  • Global contraceptives market
  • Global infertility market
  • Global menopause market
  • Global endometriosis market
  • Global polycystic ovary syndrome market

PART 07: Geographical segmentation

  • Market overview
  • Women's health market in Americas
  • Women's health market in Europe
  • Women's health market in APAC
  • Women's health market in MEA

PART 08: Market drivers

PART 09: Impact of drivers

PART 10: Market challenges

PART 11: Impact of drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape

  • Competitive scenario

PART 14: Key vendor analysis

  • Allergan
  • Bayer HealthCare
  • Merck
  • Pfizer
  • Teva Pharmaceuticals
  • Other prominent vendors

PART 15: Appendix

  • List of abbreviations

PART 16: Explore Technavio

List of Exhibits

  • Exhibit 01: Global women's health market segmentation
  • Exhibit 02: Product offerings
  • Exhibit 03: Global women's health market 2015-2020 ($ billions)
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Global women's health market segmentation by application 2015
  • Exhibit 06: Global women's health market segmentation by application 2020
  • Exhibit 07: Global women's health market by application 2015-2020 ($ billions)
  • Exhibit 08: Global women's health market by application 2015-2020 (% share)
  • Exhibit 09: Global postmenopausal osteoporosis market 2015-2020 ($ billions)
  • Exhibit 10: Global contraceptives market 2015-2020 ($ billions)
  • Exhibit 11: Global infertility market 2015-2020 ($ billions)
  • Exhibit 12: Global menopause market 2015-2020 ($ billions)
  • Exhibit 13: Global endometriosis market 2015-2020 ($ billions)
  • Exhibit 14: Global polycystic ovary syndrome market 2015-2020 ($ millions)
  • Exhibit 15: Global women's health market geographical segmentation 2015
  • Exhibit 16: Global women's health market geographical segmentation 2015-2020 ($ billions)
  • Exhibit 17: Women's health market in Americas 2015-2020 ($ billions)
  • Exhibit 18: Women's health market in Europe 2015-2020 ($ billions)
  • Exhibit 19: Women's health market in APAC 2015-2020 ($ billions)
  • Exhibit 20: Women's health market in MEA 2015-2020 ($ billions)
  • Exhibit 21: Average annual per capita growth in health spending and share of GDP in emerging countries and OECD for 2013-2014
  • Exhibit 22: Impact of drivers
  • Exhibit 23: Impact of drivers and challenges
  • Exhibit 24: Companies focusing on women's health
  • Exhibit 25: Allergan: Key takeaways
  • Exhibit 26: Bayer HealthCare: Key takeaways
  • Exhibit 27: Merck: Key takeaways
  • Exhibit 28: Pfizer: Key takeaways
  • Exhibit 29: Teva Pharmaceuticals: Key takeaways
Back to Top